Similar articles

• [Counterimmunoelectrophoresis and complement fixation in the seroepidemiology of rotaviruses].

  Cherchi GB, Coinu G, Dore A, Gakis C, Mura MS, Sotgia A, Andreoni G. Cherchi GB, et al. Nuovi Ann Ig Microbiol. 1983 Jul-Aug;34(4):287-94. Nuovi Ann Ig Microbiol. 1983. PMID: 6098895 Italian. No abstract available.
• [Who is to be vaccinated against rotaviruses?].

  Nøkleby H. Nøkleby H. Tidsskr Nor Laegeforen. 1999 Oct 30;119(26):3884. Tidsskr Nor Laegeforen. 1999. PMID: 10592743 Norwegian. No abstract available.
• New vaccines against mucosal pathogens: rotavirus and respiratory syncytial virus.

  Coffin SE, Offit PA. Coffin SE, et al. Adv Pediatr Infect Dis. 1997;13:333-48. Adv Pediatr Infect Dis. 1997. PMID: 9544318 Review. No abstract available.
• Convalescent phase sera from children infected with G12 rotavirus cross-neutralize rotavirus strains belonging to the Wa genogroup.

  Sharma S, Nakagomi T, Nakagomi O, Paul VK, Bhan MK, Ray P. Sharma S, et al. J Gen Virol. 2010 Jul;91(Pt 7):1794-9. doi: 10.1099/vir.0.019489-0. Epub 2010 Mar 17. J Gen Virol. 2010. PMID: 20237224
• Immunity and correlates of protection for rotavirus vaccines.

  Franco MA, Angel J, Greenberg HB. Franco MA, et al. Vaccine. 2006 Apr 5;24(15):2718-31. doi: 10.1016/j.vaccine.2005.12.048. Epub 2006 Jan 17. Vaccine. 2006. PMID: 16446014 Review.